✦ LIBER ✦
A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01
✍ Scribed by Joaquim Bellmunt; Pablo Maroto-Rey; José M. Trigo; Joan Carles; Vicente Guillem; José A. López-Martín; Antonio Antón-Torres; Leyrer Urruticoechea
- Book ID
- 107597681
- Publisher
- Springer Milan
- Year
- 2010
- Tongue
- Spanish
- Weight
- 291 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1699-048X
No coin nor oath required. For personal study only.